Trial intelligence / Profile preview

Phase II basket study of ICP-723 in NTRK fusion-positive advanced solid tumors or primary central nervous system tumors

CTR20223163Phase 2Active

Sponsor

Innovent Biologics

Start

Jan 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1